Literature DB >> 1728054

The comparative tumorigenic effects of fission neutrons and cobalt-60 gamma rays in the B6CF1 mouse.

D Grahn1, L S Lombard, B A Carnes.   

Abstract

In the period from 1971 to 1986, both sexes of the B6CF1 (C57BL/6 x BALB/c) mouse were exposed at 110 +/- 7 days of age to single, 24 once-weekly or 60 once-weekly doses of fission neutrons or 60Co gamma rays. A small group of males was also exposed to gamma rays for 22 h/day, 5 days/week, for either 23 or 59 weeks, the elapsed times for the 24 and 60 once-weekly series. All mice were followed for their natural lifetimes. A gross pathology report is available on 32,000 animals, and a histopathology record is available on about 19,000. About 85% died with or from one or more neoplastic diseases. The principal tumors observed at death were of lymphoreticular (45-60%), vascular (20%), or pulmonary (35-50%) origin. From 4 to 10% died with fibrosarcomas, hepatocellular tumors, ovarian tumors, and tumors of the Harderian, adrenal, and pituitary glands. Dose-response equations (linear and linear-quadratic) were fitted to the data for deaths from and occurrences of eight different individual or groups of tumors. Equations were constrained through the control intercepts and fitted separately for the two sexes, the two radiation qualities, and all exposure patterns for the two intervals of 600-799 days and 800-999 days from first exposure. RBE values were derived from the ratios of linear coefficients of dose-response curves. RBE values increased as dose was protracted, largely due to the reduced effectiveness of protracted gamma irradiation; however, about 28% of the increase can be attributed to the increase in neutron-induced injury caused by dose protraction. Highest RBE values were seen for tumors of epithelial tissue origin and the lowest for tumors of connective tissue origin. The range for significant values was from about 2 to over 50. Nonneoplastic diseases accounted for about 5% of all deaths, and 10% were classified as from unknown causes. Neither category responded to differences in radiation quality or exposure patterns.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728054

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  18 in total

1.  Past and future work on radiobiology mega-studies: a case study at Argonne National Laboratory.

Authors:  Benjamin Haley; Qiong Wang; Beau Wanzer; Stefan Vogt; Lydia Finney; Ping Liu Yang; Tatjana Paunesku; Gayle Woloschak
Journal:  Health Phys       Date:  2011-06       Impact factor: 1.316

2.  Protons and High-Linear Energy Transfer Radiation Induce Genetically Similar Lymphomas With High Penetrance in a Mouse Model of the Aging Human Hematopoietic System.

Authors:  Rutulkumar Patel; Luchang Zhang; Amar Desai; Mark J Hoenerhoff; Lucy H Kennedy; Tomas Radivoyevitch; Chiara La Tessa; Stanton L Gerson; Scott M Welford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-07-04       Impact factor: 7.038

3.  Dose and dose rate extrapolation factors for malignant and non-malignant health endpoints after exposure to gamma and neutron radiation.

Authors:  Van Tran; Mark P Little
Journal:  Radiat Environ Biophys       Date:  2017-09-22       Impact factor: 1.925

Review 4.  Tissue and data archives from irradiation experiments conducted at Argonne National Laboratory over a period of four decades.

Authors:  Qiong Wang; Tatjana Paunesku; Gayle Woloschak
Journal:  Radiat Environ Biophys       Date:  2010-03-23       Impact factor: 1.925

Review 5.  Assessing the risk of second malignancies after modern radiotherapy.

Authors:  Wayne D Newhauser; Marco Durante
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

6.  ANALYTICAL MODEL TO ESTIMATE EQUIVALENT DOSE FROM INTERNAL NEUTRONS IN PROTON THERAPY OF CHILDREN WITH INTRACRANIAL TUMORS.

Authors:  Kyle J Gallagher; Phillip J Taddei
Journal:  Radiat Prot Dosimetry       Date:  2019-06-01       Impact factor: 0.972

Review 7.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

8.  Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons.

Authors:  Leo E Gerweck; Peigen Huang; Hsiao-Ming Lu; Harald Paganetti; Yenong Zhou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

9.  On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice.

Authors:  J B Storer; R J Fry
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

Review 10.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.